Patrick Fabbio
Vermögen: 174 842 $ am 31.10.2026
Vermögen: 174 842 $ am 31.10.2026
Patrick Fabbio is currently an Independent Director at BeyondSpring, Inc. since 2018 and Chief Financial Officer at Protara Therapeutics, Inc. since 2023.
Former positions include Vice President-Finance at NPS Pharmaceuticals, Inc. from 2012 to 2015; Controller at Biomatrix, Inc.; Chief Financial Officer, Secretary & Senior Vice President at Progenics Pharmaceuticals, Inc. from 2015 to 2020; Chief Financial Officer at Ikano Therapeutics, Inc. from 2009 to 2011; Auditor at Coopers & Lybrand (London); Vice President-Finance, Innovation & Growth at Catalent Pharma Solutions, Inc.; Chief Financial Officer at electroCore, Inc.; Chief Financial Officer at WindMIL Therapeutics, Inc. from 2020 to 2021; and Chief Financial & Accounting Officer at Rafael Holdings, Inc. from 2021 to 2023.
Education includes an undergraduate degree from Pace University and an MBA from The Leonard N Stern School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.01.2026 | 64 115 ( 0,11 % ) | 159 005 $ | 31.10.2026 | |
BEYONDSPRING INC. 0,06 % | 01.04.2026 | 24 592 ( 0,06 % ) | 15 837 $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Finanzdirektor/CFO | 30.01.2023 |
| BEYONDSPRING INC. | Direktor/Vorstandsmitglied | 02.01.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| RAFAEL HOLDINGS, INC. | Finanzdirektor/CFO | 27.01.2023 |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Finanzdirektor/CFO | 01.09.2021 |
| PROGENICS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 27.03.2020 |
| NPS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.05.2015 |
Ikano Therapeutics, Inc.
Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Finanzdirektor/CFO | 18.01.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
Biomatrix, Inc.
Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets viscoelastic products | Health Technology |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Ikano Therapeutics, Inc.
Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pace University
Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coopers & Lybrand (London)
Coopers & Lybrand (London) Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
electroCore, Inc.
electroCore, Inc. Medical SpecialtiesHealth Technology Develops non-invasive neuromodulation therapies | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
BeyondSpring, Inc.
BeyondSpring, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cancer therapies | Health Technology |
Rafael Holdings, Inc.
Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
Protara Therapeutics, Inc.
Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen